Precision medicine directed therapy enabling long-term survival in medulloblastoma: a case report - Top-Institutions - MDSpire

Precision medicine directed therapy enabling long-term survival in medulloblastoma: a case report

  • By

  • Laura Vazquez

  • Jonathan Lerch

  • Divya Gandra

  • Abigail Moore

  • Jessica Lincoln

  • Abhinav B. Nagulapally

  • Suzanne Treadway

  • Krishnamoorthy Thamburaj

  • Valerie Brown

  • Giselle Saulnier Sholler

  • July 14, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Beat Childhood Cancer Research Consortium
    Beat Childhood Cancer Research Consortium

    Dallas, TX

    Key Differentiators

    • Oncology

  • #2

    HIT2000 trial
    HIT2000 trial

    N/A, N/A

    Key Differentiators

    • Oncology

  • #3

    Molecular Tumor Board
    Molecular Tumor Board

    N/A, N/A

    Key Differentiators

    • Oncology

  • #4

    IWK Health Centre
    IWK Health Centre

    Halifax, NS

    Key Differentiators

    • Oncology

  • #5

    Dalhousie University
    Dalhousie University

    Halifax, NS

    Key Differentiators

    • Oncology

Original Source(s)

Precision medicine directed therapy enabling long-term survival in medulloblastoma: a case report

  • by Laura Vazquez, Jonathan Lerch, Divya Gandra, Abigail Moore, Jessica Lincoln, Abhinav B. Nagulapally, Suzanne Treadway, Krishnamoorthy Thamburaj, Valerie Brown, Giselle Saulnier Sholler

  • July 14, 2026

Related Content

Leptomeningeal disease (LMD) after resection of brain metastases: results of the multicenter SUBAROMA study

Correction: Primary malignant peripheral nerve sheath tumor of the liver: a case report and literature review

Editorial: Molecular pathways and signaling molecules in cancer therapy: advances and innovations